Biothrax (Anthrax Vaccine) Market, Global Outlook and Forecast 2023-2029

Report ID: MMG174496 | Category: Pharma & Healthcare | Pages: 123 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
This report aims to provide a comprehensive presentation of the global market for Biothrax (Anthrax Vaccine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biothrax (Anthrax Vaccine). This report contains market size and forecasts of Biothrax (Anthrax Vaccine) in global, including the following market information:
Global Biothrax (Anthrax Vaccine) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biothrax (Anthrax Vaccine) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biothrax (Anthrax Vaccine) companies in 2022 (%)
The global Biothrax (Anthrax Vaccine) market was valued at US$ 674 million in 2022 and is projected to reach US$ 837.8 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent. 
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biothrax (Anthrax Vaccine) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biothrax (Anthrax Vaccine) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biothrax (Anthrax Vaccine) Market Segment Percentages, by Type, 2022 (%)
    Live Vaccines
    Cell Free PA Vaccines
Global Biothrax (Anthrax Vaccine) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biothrax (Anthrax Vaccine) Market Segment Percentages, by Application, 2022 (%)
    Human Use
    Animal Use
Global Biothrax (Anthrax Vaccine) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biothrax (Anthrax Vaccine) Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biothrax (Anthrax Vaccine) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biothrax (Anthrax Vaccine) revenues share in global market, 2022 (%)
Key companies Biothrax (Anthrax Vaccine) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biothrax (Anthrax Vaccine) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Merial
    Merck
    Zoetis
    Bayer Sanidad Animal
    Colorado Serum
    PharmAthene
    Tiankang
    Biogénesis-Bago
    CAVAC
    Rosenbusch
    Agrovet
    Vecol
    CVCRI
    IVPM
    Prondil
    CDV
    Indian Immunologicals
    Botswana Vaccine Institute
    Ceva Santé Animale
    Intervac
    JOVAC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biothrax (Anthrax Vaccine), market overview.
Chapter 2: Global Biothrax (Anthrax Vaccine) market size in revenue and volume.
Chapter 3: Detailed analysis of Biothrax (Anthrax Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biothrax (Anthrax Vaccine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biothrax (Anthrax Vaccine) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Biothrax (Anthrax Vaccine) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Biothrax (Anthrax Vaccine) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Biothrax (Anthrax Vaccine) Overall Market Size
    2.1 Global Biothrax (Anthrax Vaccine) Market Size: 2022 VS 2029
    2.2 Global Biothrax (Anthrax Vaccine) Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Biothrax (Anthrax Vaccine) Sales: 2018-2029
3 Company Landscape
    3.1 Top Biothrax (Anthrax Vaccine) Players in Global Market
    3.2 Top Global Biothrax (Anthrax Vaccine) Companies Ranked by Revenue
    3.3 Global Biothrax (Anthrax Vaccine) Revenue by Companies
    3.4 Global Biothrax (Anthrax Vaccine) Sales by Companies
    3.5 Global Biothrax (Anthrax Vaccine) Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Biothrax (Anthrax Vaccine) Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Biothrax (Anthrax Vaccine) Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Biothrax (Anthrax Vaccine) Players in Global Market
        3.8.1 List of Global Tier 1 Biothrax (Anthrax Vaccine) Companies
        3.8.2 List of Global Tier 2 and Tier 3 Biothrax (Anthrax Vaccine) Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Biothrax (Anthrax Vaccine) Market Size Markets, 2022 & 2029
        4.1.2 Live Vaccines
        4.1.3 Cell Free PA Vaccines
    4.2 By Type - Global Biothrax (Anthrax Vaccine) Revenue & Forecasts
        4.2.1 By Type - Global Biothrax (Anthrax Vaccine) Revenue, 2018-2023
        4.2.2 By Type - Global Biothrax (Anthrax Vaccine) Revenue, 2024-2029
        4.2.3 By Type - Global Biothrax (Anthrax Vaccine) Revenue Market Share, 2018-2029
    4.3 By Type - Global Biothrax (Anthrax Vaccine) Sales & Forecasts
        4.3.1 By Type - Global Biothrax (Anthrax Vaccine) Sales, 2018-2023
        4.3.2 By Type - Global Biothrax (Anthrax Vaccine) Sales, 2024-2029
        4.3.3 By Type - Global Biothrax (Anthrax Vaccine) Sales Market Share, 2018-2029
    4.4 By Type - Global Biothrax (Anthrax Vaccine) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Biothrax (Anthrax Vaccine) Market Size, 2022 & 2029
        5.1.2 Human Use
        5.1.3 Animal Use
    5.2 By Application - Global Biothrax (Anthrax Vaccine) Revenue & Forecasts
        5.2.1 By Application - Global Biothrax (Anthrax Vaccine) Revenue, 2018-2023
        5.2.2 By Application - Global Biothrax (Anthrax Vaccine) Revenue, 2024-2029
        5.2.3 By Application - Global Biothrax (Anthrax Vaccine) Revenue Market Share, 2018-2029
    5.3 By Application - Global Biothrax (Anthrax Vaccine) Sales & Forecasts
        5.3.1 By Application - Global Biothrax (Anthrax Vaccine) Sales, 2018-2023
        5.3.2 By Application - Global Biothrax (Anthrax Vaccine) Sales, 2024-2029
        5.3.3 By Application - Global Biothrax (Anthrax Vaccine) Sales Market Share, 2018-2029
    5.4 By Application - Global Biothrax (Anthrax Vaccine) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Biothrax (Anthrax Vaccine) Market Size, 2022 & 2029
    6.2 By Region - Global Biothrax (Anthrax Vaccine) Revenue & Forecasts
        6.2.1 By Region - Global Biothrax (Anthrax Vaccine) Revenue, 2018-2023
        6.2.2 By Region - Global Biothrax (Anthrax Vaccine) Revenue, 2024-2029
        6.2.3 By Region - Global Biothrax (Anthrax Vaccine) Revenue Market Share, 2018-2029
    6.3 By Region - Global Biothrax (Anthrax Vaccine) Sales & Forecasts
        6.3.1 By Region - Global Biothrax (Anthrax Vaccine) Sales, 2018-2023
        6.3.2 By Region - Global Biothrax (Anthrax Vaccine) Sales, 2024-2029
        6.3.3 By Region - Global Biothrax (Anthrax Vaccine) Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Biothrax (Anthrax Vaccine) Revenue, 2018-2029
        6.4.2 By Country - North America Biothrax (Anthrax Vaccine) Sales, 2018-2029
        6.4.3 US Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.4.4 Canada Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.4.5 Mexico Biothrax (Anthrax Vaccine) Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Biothrax (Anthrax Vaccine) Revenue, 2018-2029
        6.5.2 By Country - Europe Biothrax (Anthrax Vaccine) Sales, 2018-2029
        6.5.3 Germany Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.5.4 France Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.5.5 U.K. Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.5.6 Italy Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.5.7 Russia Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.5.8 Nordic Countries Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.5.9 Benelux Biothrax (Anthrax Vaccine) Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Biothrax (Anthrax Vaccine) Revenue, 2018-2029
        6.6.2 By Region - Asia Biothrax (Anthrax Vaccine) Sales, 2018-2029
        6.6.3 China Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.6.4 Japan Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.6.5 South Korea Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.6.6 Southeast Asia Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.6.7 India Biothrax (Anthrax Vaccine) Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Biothrax (Anthrax Vaccine) Revenue, 2018-2029
        6.7.2 By Country - South America Biothrax (Anthrax Vaccine) Sales, 2018-2029
        6.7.3 Brazil Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.7.4 Argentina Biothrax (Anthrax Vaccine) Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Biothrax (Anthrax Vaccine) Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Biothrax (Anthrax Vaccine) Sales, 2018-2029
        6.8.3 Turkey Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.8.4 Israel Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.8.5 Saudi Arabia Biothrax (Anthrax Vaccine) Market Size, 2018-2029
        6.8.6 UAE Biothrax (Anthrax Vaccine) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Merial
        7.1.1 Merial Company Summary
        7.1.2 Merial Business Overview
        7.1.3 Merial Biothrax (Anthrax Vaccine) Major Product Offerings
        7.1.4 Merial Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.1.5 Merial Key News & Latest Developments
    7.2 Merck
        7.2.1 Merck Company Summary
        7.2.2 Merck Business Overview
        7.2.3 Merck Biothrax (Anthrax Vaccine) Major Product Offerings
        7.2.4 Merck Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.2.5 Merck Key News & Latest Developments
    7.3 Zoetis
        7.3.1 Zoetis Company Summary
        7.3.2 Zoetis Business Overview
        7.3.3 Zoetis Biothrax (Anthrax Vaccine) Major Product Offerings
        7.3.4 Zoetis Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.3.5 Zoetis Key News & Latest Developments
    7.4 Bayer Sanidad Animal
        7.4.1 Bayer Sanidad Animal Company Summary
        7.4.2 Bayer Sanidad Animal Business Overview
        7.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Major Product Offerings
        7.4.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.4.5 Bayer Sanidad Animal Key News & Latest Developments
    7.5 Colorado Serum
        7.5.1 Colorado Serum Company Summary
        7.5.2 Colorado Serum Business Overview
        7.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Major Product Offerings
        7.5.4 Colorado Serum Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.5.5 Colorado Serum Key News & Latest Developments
    7.6 PharmAthene
        7.6.1 PharmAthene Company Summary
        7.6.2 PharmAthene Business Overview
        7.6.3 PharmAthene Biothrax (Anthrax Vaccine) Major Product Offerings
        7.6.4 PharmAthene Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.6.5 PharmAthene Key News & Latest Developments
    7.7 Tiankang
        7.7.1 Tiankang Company Summary
        7.7.2 Tiankang Business Overview
        7.7.3 Tiankang Biothrax (Anthrax Vaccine) Major Product Offerings
        7.7.4 Tiankang Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.7.5 Tiankang Key News & Latest Developments
    7.8 Biogénesis-Bago
        7.8.1 Biogénesis-Bago Company Summary
        7.8.2 Biogénesis-Bago Business Overview
        7.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Major Product Offerings
        7.8.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.8.5 Biogénesis-Bago Key News & Latest Developments
    7.9 CAVAC
        7.9.1 CAVAC Company Summary
        7.9.2 CAVAC Business Overview
        7.9.3 CAVAC Biothrax (Anthrax Vaccine) Major Product Offerings
        7.9.4 CAVAC Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.9.5 CAVAC Key News & Latest Developments
    7.10 Rosenbusch
        7.10.1 Rosenbusch Company Summary
        7.10.2 Rosenbusch Business Overview
        7.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Major Product Offerings
        7.10.4 Rosenbusch Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.10.5 Rosenbusch Key News & Latest Developments
    7.11 Agrovet
        7.11.1 Agrovet Company Summary
        7.11.2 Agrovet Biothrax (Anthrax Vaccine) Business Overview
        7.11.3 Agrovet Biothrax (Anthrax Vaccine) Major Product Offerings
        7.11.4 Agrovet Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.11.5 Agrovet Key News & Latest Developments
    7.12 Vecol
        7.12.1 Vecol Company Summary
        7.12.2 Vecol Biothrax (Anthrax Vaccine) Business Overview
        7.12.3 Vecol Biothrax (Anthrax Vaccine) Major Product Offerings
        7.12.4 Vecol Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.12.5 Vecol Key News & Latest Developments
    7.13 CVCRI
        7.13.1 CVCRI Company Summary
        7.13.2 CVCRI Biothrax (Anthrax Vaccine) Business Overview
        7.13.3 CVCRI Biothrax (Anthrax Vaccine) Major Product Offerings
        7.13.4 CVCRI Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.13.5 CVCRI Key News & Latest Developments
    7.14 IVPM
        7.14.1 IVPM Company Summary
        7.14.2 IVPM Business Overview
        7.14.3 IVPM Biothrax (Anthrax Vaccine) Major Product Offerings
        7.14.4 IVPM Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.14.5 IVPM Key News & Latest Developments
    7.15 Prondil
        7.15.1 Prondil Company Summary
        7.15.2 Prondil Business Overview
        7.15.3 Prondil Biothrax (Anthrax Vaccine) Major Product Offerings
        7.15.4 Prondil Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.15.5 Prondil Key News & Latest Developments
    7.16 CDV
        7.16.1 CDV Company Summary
        7.16.2 CDV Business Overview
        7.16.3 CDV Biothrax (Anthrax Vaccine) Major Product Offerings
        7.16.4 CDV Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.16.5 CDV Key News & Latest Developments
    7.17 Indian Immunologicals
        7.17.1 Indian Immunologicals Company Summary
        7.17.2 Indian Immunologicals Business Overview
        7.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Major Product Offerings
        7.17.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.17.5 Indian Immunologicals Key News & Latest Developments
    7.18 Botswana Vaccine Institute
        7.18.1 Botswana Vaccine Institute Company Summary
        7.18.2 Botswana Vaccine Institute Business Overview
        7.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Major Product Offerings
        7.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.18.5 Botswana Vaccine Institute Key News & Latest Developments
    7.19 Ceva Santé Animale
        7.19.1 Ceva Santé Animale Company Summary
        7.19.2 Ceva Santé Animale Business Overview
        7.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Major Product Offerings
        7.19.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.19.5 Ceva Santé Animale Key News & Latest Developments
    7.20 Intervac
        7.20.1 Intervac Company Summary
        7.20.2 Intervac Business Overview
        7.20.3 Intervac Biothrax (Anthrax Vaccine) Major Product Offerings
        7.20.4 Intervac Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.20.5 Intervac Key News & Latest Developments
    7.21 JOVAC
        7.21.1 JOVAC Company Summary
        7.21.2 JOVAC Business Overview
        7.21.3 JOVAC Biothrax (Anthrax Vaccine) Major Product Offerings
        7.21.4 JOVAC Biothrax (Anthrax Vaccine) Sales and Revenue in Global (2018-2023)
        7.21.5 JOVAC Key News & Latest Developments
8 Global Biothrax (Anthrax Vaccine) Production Capacity, Analysis
    8.1 Global Biothrax (Anthrax Vaccine) Production Capacity, 2018-2029
    8.2 Biothrax (Anthrax Vaccine) Production Capacity of Key Manufacturers in Global Market
    8.3 Global Biothrax (Anthrax Vaccine) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Biothrax (Anthrax Vaccine) Supply Chain Analysis
    10.1 Biothrax (Anthrax Vaccine) Industry Value Chain
    10.2 Biothrax (Anthrax Vaccine) Upstream Market
    10.3 Biothrax (Anthrax Vaccine) Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Biothrax (Anthrax Vaccine) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Biothrax (Anthrax Vaccine) Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?